Latest News

Journalists Tour Jinan Machine-Tool Plant Where Trainees Work on Real Orders

Correction: Norsk Hydro: Solid results and strong performance

Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA

Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer

Alnylam Announces Positive Initial Phase 1b Data for Brezosiran (ALN-HTT02) Demonstrating Deep and Durable Huntingtin Lowering in Huntington’s Disease

Georgiamune und die Menarini Group schließen eine exklusive weltweite Lizenz- und Kooperationsvereinbarung für GIM-621, ein First-in-Class-Präparat für die orale Immunonkologie

ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial

ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026

SUNMI bringt eine Produktfamilie mit Windows-Betriebssystem für den gewerblichen Einsatz auf den Markt und erweitert damit die Auswahl an Computerlösungen für den intelligenten Handel

Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer